🧠 Optimism for Neuralink’s Human Trials: Elon Musk shares an optimistic update on Neuralink’s first patient in a Fab TV interview. 📅 Expected Results Soon: Musk anticipates results from the first patient later in the week and expresses hope that the patient can control a phone and a computer using Neuralink. 🚀 Successful Implantation: On…
🧠 Neuralink’s First Human Implant: “Telepathy” – Elon Musk announces the successful implantation of Neuralink’s first human device called “Telepathy.” “Telepathy” allows users to control digital devices through brain waves. 🚀 Successful Operation and Promising Results: Musk reports that the first patient with the Neuralink implant is recovering well, and initial results are promising. 📱…
Key Points 🧠 Neuralink is actively recruiting patients for its clinical trials, The PRIME Study, focused on testing the N1 implant and R1 surgical robot for brain-computer interface (BCI). 🚀 The N1 implant aims to help people with paralysis control external devices using their thoughts. 🌐 Qualifications for PRIME Study participants include quadriplegia due to…
Key Points 👁️ Elon Musk’s Neuralink is developing a “Vision Chip” to address eye conditions causing blindness. 🧠 Neuralink is known for its work on implantable brain-computer interfaces and is moving toward human trials for its v0.9 chip to address various health issues. 🌐 The vision chip aims to tackle rising eye health issues as…
During Elon Musk’s visit to France, the billionaire estimated that Neuralink would start its first human trial before the end of this year. “It’s looking like the first case will be later this year,” said Elon Musk during an interview at the VivaTech event in Paris. Neuralink posted its patient registry on its official website. Neuralink’s patient…
Neuralink may take 10 more years to commercialize its brain-machine interface (BMI) device, estimated Kip Ludwig, the former program director of neural engineering at the United States National Institutes of Health (NIH). Last month, Elon Musk’s brain implant startup celebrated a significant milestone. The U.S. Federal Drug and Food Administration (FDA) approved Neuralink’s first human clinical…
Elon Musk’s brain-computer interface startup, Neuralink, recently announced that it had received approval from the Food and Drug Administration (FDA) to conduct its first in-human clinical study. The company highlighted the milestone in a post on its official Twitter account. As noted by Neuralink, the FDA permission is the culmination of the work that the…
Recent reports have suggested that the majority of committee members overseeing animal testing at Neuralink possess financial interests in the brain-machine startup. Neuralink has been conducting animal trials as it seeks to secure permission to start human trials. Elon Musk mentioned last year that Neuralink is hoping to secure permission for human trials in about…
Neuralink launched a patient registry to learn more about specific medical conditions to improve its brain implant. Neuralink is specifically looking for patients with the following conditions: tetraplegia or tetraparesis, paraplegia, vision loss, deafness, and aphasia. Tetraplegia (also known as quadriplegia) or tetraparesis is a condition where the patients experience paralysis or cannot move all…
Amidst Elon Musk’s continued arguments against notable members of the Democratic Party on Twitter, US House Representatives Earl Francis Blumenauer and Adam Schiff have called for more scrutiny of Musk’s brain-machine startup, Neuralink. In a draft letter to the USDA, Blumenauer and Schiff — who also happen to be members of the Congressional Animal Protection…